EXPLANATORY STATEMENT
Due to clause 14.8.6. of the Exchange company rules „About listing and trade of the financial instruments within Exchange regulated markets” „Rīgas farmaceitiskā fabrika” JSC explains, that the expenses, metioned in the audited Annual report, are corrected relating to the performed marketing and advertising expenses of the products to current reporting period. According to the correction of manufacturing expenses, the reevaluation of stock of final products was performed. The item concerning the deferred corporate income tax was included in the audited annual report.
JSC „Rīgas farmaceitiskā fabrika”
Chairman of the Board
K.Bāliņš